MedPath

Tamysin 0.2

Brand Name: Tamysin 0.2

Generic Name: Tamsulosin Hydrochloride

Active
Registration Number

DRP-6482

Dosage Form

Prolonged Release Tablet

Issuance Date

April 1, 2025

Expiry Date

January 25, 2038

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength200 mcg
PackagingIn a box of 3 alu-alu blister pack x 10's

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Alpha-adrenoreceptor antagonist
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Tamsulosin HydrochlorideActive
Monograph: Tamsulosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform